Top Health trends
October 26, 2026
Real, editorialised trend snapshots from thousands of sources in 50 countries — updated daily, archived forever, open to everyone.
Pulse · Category
Top 9 Health — October 26, 2026
- 01
Amgen's UPLIZNA Approved for Myasthenia Gravis
The FDA has approved Amgen's UPLIZNA (inebilizumab-cdon) for the treatment of Generalized Myasthenia Gravis, an autoimmune neuromuscular disease. This expands treatment options for patients.
Trending in United States - 02
FDA Delays Cancer Therapy Approval
The FDA has requested another trial for Tovecimig plus Paclitaxel as a second-line therapy for advanced biliary tract cancer, causing CMPX stock to fall to over 2-year lows.
Trending in United States - 03
Conduction System Pacing Trials
Conduction system pacing trials show inconsistent results, missing noninferiority relative to biventricular pacing.
Trending in United States - 04
Adult ADHD and Autism Diagnosis
The de-diagnosis and revisability of adult ADHD and autism are discussed, alongside the impact of diagnosis on individuals seeking support.
Trending in United States - 05
Cytokine Autoimmune Inflammation CNS
Cytokine-mediated autoimmune inflammation affects the central nervous system.
Trending in United States - 06
Hepatocellular Carcinoma Treatment Study
A nationwide multicenter retrospective study reviews first-line treatment for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma using atezolizumab plus bevacizumab with or without transarterial chemoembolization.
Trending in United States - 07
Macular Degeneration Drug Comparison
Choroidal structural changes were observed following intravitreal injections of faricimab or aflibercept 8 mg in patients with neovascular age-related macular degeneration.
Trending in United States - 08
Sleep Medicine Guideline
The American Academy of Sleep Medicine has issued a clinical practice guideline for managing shift work disorder.
Trending in United States - 09
Nivolumab plus Ipilimumab Approval
The Taiwan FDA approved nivolumab plus ipilimumab for patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer, based on findings from CheckMate 8HW.
Trending in United States
See trends evolve in real time
This page is yesterday's snapshot — create a free account to see and track trends evolving in real time, discover trends before everyone else, set alerts, and even generate articles.